The medium-sized company develops and produces 3D printers and grayscale lithography systems as well as specially developed printing materials and application-specific solutions for various microfabrication applications. The specialist for additive manufacturing of high-precision structures and objects on the nano-, micro- and mesoscale was founded in 2007 as a spin-off of the Karlsruhe Institute of Technology (KIT) and is part of the BICO Group since June 2021. More than 3,000 users and operators at top universities and innovative companies worldwide benefit from the groundbreaking technology and application tailored solutions for 3D Microfabrication. Nanoscribe has created its strong market leading position through high quality engineering and agility to continuously develop its products to meet customers’ high expectations.
About PHIX B.V.
PHIX offers assembly services and contract manufacturing for photonic integrated circuits (PICs) and MEMS. We build optoelectronic modules based on all major PIC technology platforms, such as Indium Phosphide, Silicon Photonics, Silicon Nitride, and Planar Lightwave Circuit. We specialize in chip-to-chip hybrid integration, coupling to fiber arrays, and interfacing of DC and RF electrical signals. By offering our knowledge already at the chip design stage, we ensure ease of scale-up for volume manufacturing. PHIX provides a one-stop-shop for PIC and MEMS assembly, from design to volume production. We have a state-of-the-art production facility located at the High Tech Factory in Enschede, the Netherlands, supporting the global industrial development of PIC and MEMS enabled modules.
Founded in 2016, BICO (formerly CELLINK) is the leading bio convergence company in the world. By combining different technologies, such as robotics, artificial intelligence, computer science, and 3D bioprinting with biology, we enable our customers to improve people’s health and lives for the better.
The company has a focus on developing technologies that will advance Health 4.0 Next Generation Core Industry Ecosystems that enable tissue engineering, diagnostics, multiomics, and cell line development. BICO’s technologies enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. We create the future of health.
The Group’s instruments in the field amounts to 25,000, including all the top 20 pharmaceutical companies, are being used in more than 65 countries, and have been cited in more than 9,500 publications. BICO is listed on Nasdaq Stockholm under BICO. www.bico.com
Img. 1: Microscope image of a 3D-printed lensed fiber array (LFA). The microscope image clearly demonstrates how precise the optical projection of lensed fibers is. Here, green light is collimated into parallel light beams. Sample of the research project MiLiQuant.
Img. 2: The Quantum X align features the first-ever microfabrication system within an industry-proven lithographic platform, advancing photonic packaging with nano-precision alignment capabilities.
Right of use and media relations
Our image may be used free of charge for editorial purposes. Please state the source as follows: "Image: Nanoscribe, www.nanoscribe.com". The image must not be used for commercial purposes or passed on to third parties.
In case of questions or if you would like to be added to our press mailing list, please do not hesitate to contact Dr. Alena Kirchenbauer, email@example.com.
Stay up to date with our latest press releases about Nanoscribe and the world of 3D Microfabrication. Directly get in touch with us to discuss further press activities: Media relations